Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1997 Aug;81(8):649–653. doi: 10.1136/bjo.81.8.649

Primary association of HLA-B51 with Behçet's disease in Ireland

D Kilmartin 1, A Finch 1, R Acheson 1
PMCID: PMC1722271  PMID: 9349151

Abstract

AIMS/BACKGROUND—While a primary association of HLA-B51 with Behçet's disease (BD) in Japanese and Mediterranean patients supports an immunogenetic predisposition, this link is unclear in north western Europe. This study assessed HLA associations with BD, and HLA-B51 with certain clinical characteristics, in the Republic of Ireland, which has an ethnically homogeneous population.
METHODS—HLA-A, HLA-B, and HLA-DR typing was performed in 24 BD patients, conforming to International Study Group criteria, and in blood donors, as controls. Patient records were retrospectively reviewed and patients reassessed clinically.
RESULTS—A highly significant HLA-B51 association (corrected exact p value = 0.002, relative risk = 6.3) with BD was determined, despite a low B51 prevalence (25%) in patients. No other HLA type was associated. There was a significant B51 link with male sex in BD patients but no association with age at first manifestation/diagnosis, eye involvement, cyclosporin A therapy, or poor visual acuity was determined.
CONCLUSIONS—This study supports a HLA-B51 immunogenetic predisposition, similar to Japanese patients, in Irish BD in an ethnically homogeneous population in north western Europe. However, owing to a low prevalence of B51 positivity in BD patients in Ireland, a multifactorial pathogenesis is suggested.



Full Text

The Full Text of this article is available as a PDF (109.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arber N., Klein T., Meiner Z., Pras E., Weinberger A. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis. 1991 Jun;50(6):351–353. doi: 10.1136/ard.50.6.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chajek-Shaul T., Pisanty S., Knobler H., Matzner Y., Glick M., Ron N., Rosenman E., Brautbar C. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med. 1987 Oct;83(4):666–672. doi: 10.1016/0002-9343(87)90896-5. [DOI] [PubMed] [Google Scholar]
  3. Chamberlain M. A. Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977 Dec;36(6):491–499. doi: 10.1136/ard.36.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chung Y. M., Tsai S. T., Liao F., Liu J. H. A genetic study of Behçet's disease in Taiwan Chinese. Tissue Antigens. 1987 Aug;30(2):68–72. doi: 10.1111/j.1399-0039.1987.tb01599.x. [DOI] [PubMed] [Google Scholar]
  5. Cochereau-Massin I., Wechsler B., Le Hoang P., Le Thi Huong D. u., Girard B., Rousselie F., Godeau P. Pronostic oculaire de la maladie de Behçet. J Fr Ophtalmol. 1992;15(5):343–347. [PubMed] [Google Scholar]
  6. Collum L. M., Mullaney J., Bowell R. Current concepts of Behçet's disease. Trans Ophthalmol Soc U K. 1981;101(Pt 4):422–428. [PubMed] [Google Scholar]
  7. Gail M., Williams R., Byar D. P., Brown C. How many controls? J Chronic Dis. 1976 Nov;29(11):723–731. doi: 10.1016/0021-9681(76)90073-4. [DOI] [PubMed] [Google Scholar]
  8. Hayasaka S., Kurome H., Noda S. HLA antigens in a Japanese family with Behçet's disease. Graefes Arch Clin Exp Ophthalmol. 1994 Oct;232(10):589–590. doi: 10.1007/BF00193118. [DOI] [PubMed] [Google Scholar]
  9. Jankowski J., Crombie I., Jankowski R. Behçet's syndrome in Scotland. Postgrad Med J. 1992 Jul;68(801):566–570. doi: 10.1136/pgmj.68.801.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Keane J. R. Neuro-ophthalmologic signs and symptoms of cysticercosis. Arch Ophthalmol. 1982 Sep;100(9):1445–1448. doi: 10.1001/archopht.1982.01030040423010. [DOI] [PubMed] [Google Scholar]
  11. Kim M. S., Kim J. H. Prognostic comparison of Behçet's disease with or without HLA-Bw 51 antigen. Korean J Ophthalmol. 1989 Dec;3(2):85–89. doi: 10.3341/kjo.1989.3.2.85. [DOI] [PubMed] [Google Scholar]
  12. Lee S., Koh Y. J., Kim D. H., Bang D., Nam I. W., Lee K. H., Park K. A study of HLA antigens in Behçet's syndrome. Yonsei Med J. 1988;29(3):259–262. doi: 10.3349/ymj.1988.29.3.259. [DOI] [PubMed] [Google Scholar]
  13. Lehner T., Batchelor J. R., Challacombe S. J., Kennedy L. An immunogenetic basis for the tissue involvement in Behçet's syndrome. Immunology. 1979 Aug;37(4):895–900. [PMC free article] [PubMed] [Google Scholar]
  14. Meenken C., Rothova A., de Waal L. P., van der Horst A. R., Mesman B. J., Kijlstra A. HLA typing in congenital toxoplasmosis. Br J Ophthalmol. 1995 May;79(5):494–497. doi: 10.1136/bjo.79.5.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mizuki N., Inoko H., Ando H., Nakamura S., Kashiwase K., Akaza T., Fujino Y., Masuda K., Takiguchi M., Ohno S. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol. 1993 Oct 15;116(4):406–409. doi: 10.1016/s0002-9394(14)71396-0. [DOI] [PubMed] [Google Scholar]
  16. Mizuki N., Inoko H., Mizuki N., Tanaka H., Kera J., Tsuiji K., Ohno S. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51. Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3332–3340. [PubMed] [Google Scholar]
  17. Mizuki N., Ohno S., Tanaka H., Sugimura K., Seki T., Mizuki N., Kera J., Inaba G., Tsuji K., Inoko H. Association of HLA-B51 and lack of association of class II alleles with Behçet's disease. Tissue Antigens. 1992 Jul;40(1):22–30. doi: 10.1111/j.1399-0039.1992.tb01953.x. [DOI] [PubMed] [Google Scholar]
  18. Mizushima Y. Recent research into Behçet's disease in Japan. Int J Tissue React. 1988;10(2):59–65. [PubMed] [Google Scholar]
  19. Moore S. B., O'Duffy J. D. Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol. 1986 Aug;13(4):771–773. [PubMed] [Google Scholar]
  20. O'Duffy J. D. Behçet's syndrome. N Engl J Med. 1990 Feb 1;322(5):326–328. doi: 10.1056/NEJM199002013220509. [DOI] [PubMed] [Google Scholar]
  21. O'Duffy J. D., Taswell H. F., Elveback L. R. HL-A antigens in Behcet's disease. J Rheumatol. 1976 Mar;3(1):1–3. [PubMed] [Google Scholar]
  22. Ono S., Aoki K., Sugiura S., Nakayama E., Itakura K. Letter: HL-A5 and Behçet's disease. Lancet. 1973 Dec 15;2(7842):1383–1384. doi: 10.1016/s0140-6736(73)93343-6. [DOI] [PubMed] [Google Scholar]
  23. Sakamoto M., Akazawa K., Nishioka Y., Sanui H., Inomata H., Nose Y. Prognostic factors of vision in patients with Behçet disease. Ophthalmology. 1995 Feb;102(2):317–321. doi: 10.1016/s0161-6420(95)31022-6. [DOI] [PubMed] [Google Scholar]
  24. Soylu M., Ersöz T. R., Erken E. The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey. Acta Ophthalmol (Copenh) 1992 Dec;70(6):786–789. doi: 10.1111/j.1755-3768.1992.tb04888.x. [DOI] [PubMed] [Google Scholar]
  25. Villanueva J. L., Gonzalez-Dominguez J., Gonzalez-Fernandez R., Prada J. L., Peña J., Solana R. HLA antigen familial study in complete Behçet's syndrome affecting three sisters. Ann Rheum Dis. 1993 Feb;52(2):155–157. doi: 10.1136/ard.52.2.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Walter S. D. Determination of significant relative risks and optimal sampling procedures in prospective and retrospective comparative studies of various sizes. Am J Epidemiol. 1977 Apr;105(4):387–397. doi: 10.1093/oxfordjournals.aje.a112395. [DOI] [PubMed] [Google Scholar]
  27. Wechsler B., Piette J. C. Behçet's disease. BMJ. 1992 May 9;304(6836):1199–1200. doi: 10.1136/bmj.304.6836.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yazici H., Tuzun Y., Pazarli H., Yalcin B., Yurdakul S., Muftuoglu A. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol. 1980 Mar-Apr;7(2):206–210. [PubMed] [Google Scholar]
  29. Yurdakul S., Günaydin I., Tüzün Y., Tankurt N., Pazarli H., Ozyazgan Y., Yazici H. The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15(5):820–822. [PubMed] [Google Scholar]
  30. Zervas J., Vayopoulos G., Sakellaropoulos N., Kaklamanis P., Fessas P. HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks. Clin Exp Rheumatol. 1988 Jul-Sep;6(3):277–280. [PubMed] [Google Scholar]
  31. Zierhut M., Saal J., Pleyer U., Kötter I., Dürk H., Fierlbeck G. Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patients. Ger J Ophthalmol. 1995 Jul;4(4):246–251. [PubMed] [Google Scholar]
  32. Zouboulis C. C., Büttner P., Djawari D., Kirch W., Keitel W., Garbe C., von Keyserlingk-Eberius H. J., Orfanos C. E. HLA-Muster bei Morbus Adamantiades-Behçet in Deutschland. Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt. 1993 Feb;44(2):81–85. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES